BIOFORCE NANOSCIENCES HOLDINGS, INC.

BFNH ·Technology, Scientific & Technical Instruments, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $786 $862 $638 $734 $11.1K $39.9K $52.9K $29.4K
Accounts Receivable $5.7K
Inventory
Total Current Assets $786 $862 $638 $734 $11.1K $39.9K $58.9K $35.1K
Property, Plant & Equipment
Goodwill
Intangible Assets (Excl. Goodwill)
Total Assets $786 $862 $638 $734 $11.1K $39.9K $58.9K $35.1K
Liabilities
Accounts Payable
Total Current Liabilities $619.3K $2.3M $1.8M $1.3M $873.0K $399.8K $11.6K $5.3K
Long-Term Debt
Total Liabilities $619.3K $2.3M $1.8M $1.3M $873.0K $399.8K $11.6K $5.3K
Stockholders' Equity
Retained Earnings $-162.4M $-161.1M $-160.6M $-160.2M $-159.7M $-159.2M $-761.8K $-715.2K
Total Stockholders' Equity $-618.5K $-2.3M $-1.8M $-1.3M $-861.9K $-359.9K $47.3K $29.8K
← Newer Page 1 of 2 Older →
Benjamin Graham

Abnormally good or abnormally bad conditions do not last forever.